Search research articles
Contact Us
Filters
Showing results (11-20 of 70) with videos related to
Page
of 7
Sort By:
Analytical and Bioanalytical Chemistry
|
July 9, 2008
Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat
Bertrand R Brunet, Allan J Barnes, Karl B Scheidweiler, et al.
Journal of Analytical Toxicology
|
August 30, 2011
(±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice
Karl B Scheidweiler, Bruce Ladenheim, Allan J Barnes, et al.
Journal of Chromatography. A
|
July 21, 2007
Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry
Ross H Lowe, Erin L Karschner, Eugene W Schwilke, et al.
Analytical and Bioanalytical Chemistry
|
August 20, 2013
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
Sebastien Anizan, Garry Milman, Nathalie Desrosiers, et al.
Analytical and Bioanalytical Chemistry
|
March 23, 2010
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma
Erin L Karschner, Allan J Barnes, Ross H Lowe, et al.
Clinical Chemistry
|
June 17, 2011
Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence
Dayong Lee, Garry Milman, Allan J Barnes, et al.
Journal of Chromatography. A
|
April 17, 2016
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry
Madeleine J Swortwood, Karl B Scheidweiler, Allan J Barnes, et al.
Clinical Chemistry
|
January 26, 2012
Cannabinoid disposition in oral fluid after controlled smoked cannabis
Dayong Lee, David M Schwope, Garry Milman, et al.
Drug and Alcohol Dependence
|
November 14, 2012
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Dayong Lee, Erin L Karschner, Garry Milman, et al.
Forensic Science International
|
May 22, 2014
Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine
Allan J Barnes, Sheena Young, Eliani Spinelli, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 70) with videos related to
Sort By:
Page
of 7
Analytical and Bioanalytical Chemistry
|
July 9, 2008
Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat
Bertrand R Brunet, Allan J Barnes, Karl B Scheidweiler, et al.
Journal of Analytical Toxicology
|
August 30, 2011
(±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice
Karl B Scheidweiler, Bruce Ladenheim, Allan J Barnes, et al.
Journal of Chromatography. A
|
July 21, 2007
Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry
Ross H Lowe, Erin L Karschner, Eugene W Schwilke, et al.
Analytical and Bioanalytical Chemistry
|
August 20, 2013
Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers
Sebastien Anizan, Garry Milman, Nathalie Desrosiers, et al.
Analytical and Bioanalytical Chemistry
|
March 23, 2010
Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma
Erin L Karschner, Allan J Barnes, Ross H Lowe, et al.
Clinical Chemistry
|
June 17, 2011
Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence
Dayong Lee, Garry Milman, Allan J Barnes, et al.
Journal of Chromatography. A
|
April 17, 2016
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry
Madeleine J Swortwood, Karl B Scheidweiler, Allan J Barnes, et al.
Clinical Chemistry
|
January 26, 2012
Cannabinoid disposition in oral fluid after controlled smoked cannabis
Dayong Lee, David M Schwope, Garry Milman, et al.
Drug and Alcohol Dependence
|
November 14, 2012
Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
Dayong Lee, Erin L Karschner, Garry Milman, et al.
Forensic Science International
|
May 22, 2014
Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine
Allan J Barnes, Sheena Young, Eliani Spinelli, et al.
Page
of 7